Trading Update | 13-May-2024 | 07:45 | RNS |
Holding(s) in Company | 25-Apr-2024 | 15:45 | RNS |
Holding(s) in Company | 24-Apr-2024 | 08:45 | RNS |
Holding(s) in Company - REPLACEMENT | 23-Apr-2024 | 14:03 | RNS |
Holding(s) in Company | 22-Apr-2024 | 16:37 | RNS |
Top Pharma Company evaluates Optimer for medicine | 22-Apr-2024 | 07:00 | RNS |
TR-1: Notification of major holdings | 18-Apr-2024 | 10:06 | RNS |
Aptamer and Kairos Biotech partner for Optimer+ | 18-Apr-2024 | 07:00 | RNS |
Patent submission for Optimer® binders | 08-Apr-2024 | 07:00 | RNS |
Holding(s) in Company | 28-Mar-2024 | 14:07 | RNS |
Interim Results | 28-Mar-2024 | 07:00 | RNS |
Notice of Interim Results & Investor Presentation | 22-Mar-2024 | 07:00 | RNS |
Aptamer Progresses Partnership with Unilever | 11-Mar-2024 | 07:00 | RNS |
Block Listing Interim Review | 29-Feb-2024 | 07:00 | RNS |
R&D progress on new Optimer®+ platform | 27-Feb-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.75p |
Change Today | -0.075p |
% Change | -9.09 % |
52 Week High | 17.50 |
52 Week Low | 0.50 |
Volume | 6,184,391 |
Shares Issued | 467.34m |
Market Cap | £3.51m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:18 | 100,000 @ 0.72p |
16:09 | 45,000 @ 0.72p |
14:51 | 4,758 @ 0.72p |
14:04 | 4,758 @ 0.80p |
13:52 | 56,000 @ 0.72p |
You are here: research